AffinityImmuno specializes in bioanalytical ELISA kits and anti-idiotype antibodies designed for biologics and biosimilar research.
The product portfolio is optimized for pharmacokinetic (PK), anti-drug antibody (ADA), and immunogenicity studies, supporting bioanalytical workflows across drug development and translational research.
Key Strengths
- ELISA kits designed for PK and ADA analysis
- Coverage of widely used therapeutic biologics
- High-specificity anti-idiotype antibodies
- Support for custom assay development
Core Product Areas
ELISA Kits
High-quality, ready-to-use ELISA kits developed for pharmacokinetic and immunogenicity studies. These assays are designed to deliver consistent performance, helping reduce assay development time and improve reproducibility in biologics and biosimilar programs.
Anti-Idiotype Antibodies
Highly specific antibodies targeting the idiotype region of therapeutic antibodies. These reagents are suitable for assay development, capture systems, and improving specificity in bioanalytical workflows.
Key Target Biologics
Adalimumab (Humira), Bevacizumab (Avastin), Cetuximab (Erbitux), Etanercept (Enbrel), Infliximab (Remicade), Pembrolizumab (Keytruda), Pertuzumab (Perjeta), Rituximab (Rituxan), Trastuzumab (Herceptin)
Advantages of Chicken IgY
- Higher affinity against mammalian proteins
- Improved specificity in assay development
- No binding to mammalian Fc receptors, complement, or Protein A/G
- Reduced background in ELISA applications
Typical Applications
- Pharmacokinetic (PK) analysis
- Anti-drug antibody (ADA) testing
- Immunogenicity assessment
- Bioanalytical method development
- Support for CRO and CDMO workflows
